Gedea Biotech Ab
Clinical trials sponsored by Gedea Biotech Ab, explained in plain language.
-
New Non-Antibiotic BV treatment shows promise in early safety testing
Disease control Recruiting nowThis study is testing the safety of a new vaginal tablet called pHyph for treating bacterial vaginosis (BV). Thirty-two women with BV will use the tablets for 12 days while researchers monitor for any side effects. The treatment aims to restore the vagina's natural acidity to hel…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Non-Drug tablet aims to soothe common yeast infection misery
Symptom relief Recruiting nowThis study is testing a vaginal tablet called pHyph to see if it can reduce the itching, burning, and irritation caused by yeast infections (thrush). Researchers will compare the tablet's effects to no treatment in 48 adult women with active symptoms. The goal is to see if this n…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Symptom relief
Last updated Apr 04, 2026 12:35 UTC